Scientific Committee
The Scientific Committee was formed to optimize collaborative, translational research linked to NACHO clinical studies in order to improve patient outcomes and identify and test improved clinical approaches.
Carl Allen, MD, PhD - Chairperson
Texas Children’s Cancer Center, Baylor College of Medicine
Houston, TX USA
Michelle Hermiston, MD, PhD
University of California San Francisco
San Francisco, CA USA
Michael Hogarty, MD
The Children’s Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania
Philadelphia, PA USA
Michael B. Jordan, MD
Cincinnati Children's Hospital Medical Center
Cincinnati, OH USA
Miriam Merad, MD, PhD
Icahn School of Medicine at Mount Sinai
New York, NY USA
D. Williams Parsons, MD, PhD
Baylor College of Medicine, Texas Children's Cancer Center
Houston, TX USA
Carlos Rodriguez-Galindo, MD
St. Jude Children's Research Hospital
Memphis, TN USA
Barrett Rollins, MD, PhD
Harvard Medical School, Dana-Farber Cancer Institute
Boston, MA USA
Texas Children’s Cancer Center, Baylor College of Medicine
Houston, TX USA
Michelle Hermiston, MD, PhD
University of California San Francisco
San Francisco, CA USA
Michael Hogarty, MD
The Children’s Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania
Philadelphia, PA USA
Michael B. Jordan, MD
Cincinnati Children's Hospital Medical Center
Cincinnati, OH USA
Miriam Merad, MD, PhD
Icahn School of Medicine at Mount Sinai
New York, NY USA
D. Williams Parsons, MD, PhD
Baylor College of Medicine, Texas Children's Cancer Center
Houston, TX USA
Carlos Rodriguez-Galindo, MD
St. Jude Children's Research Hospital
Memphis, TN USA
Barrett Rollins, MD, PhD
Harvard Medical School, Dana-Farber Cancer Institute
Boston, MA USA